home / stock / ovid / ovid quote
Last: | $3.34 |
---|---|
Change Percent: | -3.23% |
Open: | $3.2 |
Close: | $3.34 |
High: | $3.36 |
Low: | $3.145 |
Volume: | 311,342 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.34 | $3.2 | $3.34 | $3.36 | $3.145 | 311,342 | 04-29-2024 |
$3.1 | $2.99 | $3.1 | $3.13 | $2.99 | 80,529 | 04-26-2024 |
$2.99 | $3.13 | $2.99 | $3.14 | $2.99 | 112,117 | 04-25-2024 |
$3.15 | $3.18 | $3.15 | $3.216 | $3.11 | 113,127 | 04-24-2024 |
$3.2 | $3.16 | $3.2 | $3.2441 | $3.11 | 110,572 | 04-23-2024 |
$3.15 | $3.23 | $3.15 | $3.29 | $3.12 | 205,940 | 04-22-2024 |
$3.23 | $3.19 | $3.23 | $3.29 | $3.17 | 176,642 | 04-19-2024 |
$3.21 | $3.12 | $3.21 | $3.24 | $3.12 | 226,932 | 04-18-2024 |
$3.11 | $3.18 | $3.11 | $3.22 | $3.05 | 160,465 | 04-17-2024 |
$3.17 | $3.18 | $3.17 | $3.23 | $3.15 | 138,008 | 04-16-2024 |
$3.2 | $3.21 | $3.2 | $3.24 | $3.198 | 131,931 | 04-15-2024 |
$3.2 | $3.24 | $3.2 | $3.24 | $3.13 | 88,254 | 04-12-2024 |
$3.27 | $3.19 | $3.27 | $3.29 | $3.1734 | 76,652 | 04-11-2024 |
$3.18 | $3.18 | $3.18 | $3.2118 | $3.1101 | 167,577 | 04-10-2024 |
$3.24 | $3.22 | $3.24 | $3.3225 | $3.2 | 136,252 | 04-09-2024 |
$3.22 | $3.23 | $3.22 | $3.27 | $3.199 | 56,495 | 04-08-2024 |
$3.25 | $3.14 | $3.25 | $3.35 | $3.06 | 186,042 | 04-05-2024 |
$3.05 | $3.09 | $3.05 | $3.15 | $3.05 | 93,251 | 04-04-2024 |
$3.05 | $3.05 | $3.05 | $3.09 | $3.03 | 89,963 | 04-03-2024 |
$3.05 | $3.02 | $3.05 | $3.12 | $3 | 200,077 | 04-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ovid Therapeutics Inc. Company Name:
OVID Stock Symbol:
NASDAQ Market:
Ovid Therapeutics Inc. Website:
2024-04-04 18:15:03 ET Wedbush analyst issues OUTPERFORM recommendation for OVID on April 4, 2024 04:19PM ET. OVID was trading at $3.05 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company dedicated to meaningfully improvi...
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, today announced that management will participate in a virtual presentation at t...